Abstract (EN):
Background: Fabry disease (FD) is a rare metabolic lysosomal disorder in which
a deficiency of alpha galactosidase A enzyme activity leads to accumulation
of glycosphingolipids, mainly in vascular endothelial and smooth-muscle cells.
Cerebrovascular disease (CVD) is a major manifestation of FD. A beneficial
impact of enzyme replacement therapy (ERT) on FD related CVD has not yet
been conclusively demonstrated and careful neurological follow up is strongly
recommended. We describe the results of this follow-up in a series of FD patients
(pts).
Methods: We have prospectively evaluated 12 (5 males) FD pts from 4 different
families with classic FD phenotype. FD had been diagnosed at the mean ages of
19.0y in males and 34.4y in females. All pts had a comprehensive neurological
clinical evaluation and underwent cervical and transcranial vascular ultrasound and
brain magnetic resonance imaging (MRI) with angiography.
Results: Median ages at evaluation were 23y (range: 21-48) for males and 44y
(range: 26-54) for females. Six pts had acroparesthesias, 2 hypohidrosis and 8
abdominal complaints. Angiokeratomas were present in 7, cornea verticillata in 9,
cardiac involvement in 3 and renal manifestations in 7. Eight pts had non-specific
headaches and 2 females had psychiatric disorders. None of the pts reported
previous stroke, although 1 female had a mild right upper limb paresis. Eight pts
(3 females) were on ERT. Brain MRI showed ischaemic lesions, mostly in white
matter, in the only male and in 2 of the 3 females aged >45y. Two males (mean
age: 35.5y) and 4 females (mean age: 47y) had tortuous and/or dilated intracranial
arteries.
Discussion: These data are consistent with the known natural history and manifestations
of CVD in FD pts. MRI is a sensitive method to screen for the
typical ischaemic brain lesions and structural arterial changes associated with FD,
including in pts without overt stroke. Arterial changes were present since the 3rd
decade of life. Despite X-linked inheritance, the prevalence of cerebrovascular
lesions in heterozygous females aged >35y is high.
Language:
Portuguese
Type (Professor's evaluation):
Scientific
Contact:
Maria Amélia Mendes